Valuation : Evotec SE

Market Cap 59Cr 68Cr 55Cr 50Cr 94Cr 6.43TCr 95Cr 655.37Cr 254.35Cr 3.29TCr 255.78Cr 250.19Cr 11TCr P/E 2026 *
-2.82x
P/E 2027 * -7.68x
Enterprise Value 73Cr 85Cr 69Cr 63Cr 117.19Cr 8TCr 118.07Cr 814.69Cr 316.18Cr 4.09TCr 317.96Cr 311.01Cr 13TCr EV / Sales 2026 *
1.22x
EV / Sales 2027 * 1.04x
Free-Float
89.91%
Yield 2026 *
-
Yield 2027 * -
1 day+4.95%
1 week-1.43%
Current month+1.85%
1 month-3.05%
3 months-35.11%
6 months-41.86%
Current year-39.34%
1 week 3.12
Extreme 3.118
3.41
1 month 3.12
Extreme 3.118
3.88
Current year 3.12
Extreme 3.118
6.73
1 year 3.12
Extreme 3.118
7.3
3 years 3.12
Extreme 3.118
23.44
5 years 3.12
Extreme 3.118
45.83
10 years 3.12
Extreme 3.118
45.83
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO - 01/05/2026
Chief Operating Officer - 01/05/2026
Director TitleAgeSince
Director/Board Member 58 19/06/2019
Director/Board Member 64 01/06/2021
Director/Board Member 59 10/06/2024
Date Insider Type Main position Quantity % Market Cap. Importance
20/05/26 Exercice

Chief Technology Officer

12,462 0.0070%
04/05/26 Buy 15,510 0.0087%
04/05/26 Buy

Head of Human Resources

15,228 0.0086%
Change 5-day change 1-year change 3-year change Capi.($)
+4.95%-1.43%-42.90%-84.79% 65Cr
+0.97%-0.75%+3.51%+18.46% 4.97TCr
-0.30%-2.88%+429.29%+496.95% 4.5TCr
+2.13%+0.89%+43.59%+17.61% 4.25TCr
+0.87%-3.73%+8.96%+73.17% 4.08TCr
-0.90%-3.67%+14.26%+48.44% 3.29TCr
+2.71%+6.82% - - 1.71TCr
+1.68%-4.20%+25.28%+116.83% 1.63TCr
+1.70%-0.05%+18.53%+28.50% 1.44TCr
+3.34%-1.13%+80.94%+39.19% 1.35TCr
Average +1.72%-1.28%+64.61%+83.82% 2.73TCr
Weighted average by Cap. +1.02%-1.78%+93.52%+122.73%

Financials

2026 *2027 *
Net sales 60Cr 70Cr 56Cr 51Cr 96Cr 6.57TCr 97Cr 668.8Cr 259.56Cr 3.36TCr 261.02Cr 255.32Cr 11TCr 72Cr 83Cr 68Cr 62Cr 115.38Cr 7.88TCr 116.24Cr 802.09Cr 311.29Cr 4.03TCr 313.05Cr 306.2Cr 13TCr
Net income -24Cr -27Cr -22Cr -20Cr -38Cr -2.58TCr -38Cr -263.02Cr -102.08Cr -1.32TCr -102.65Cr -100.41Cr -4.34TCr -6.04Cr -7Cr -5.69Cr -5.18Cr -9.69Cr -661.07Cr -9.76Cr -67Cr -26Cr -337.98Cr -26Cr -26Cr -1.11TCr
Net Debt 14Cr 17Cr 13Cr 12Cr 23Cr 1.56TCr 23Cr 159.32Cr 62Cr 799.73Cr 62Cr 61Cr 2.63TCr 16Cr 19Cr 15Cr 14Cr 26Cr 1.78TCr 26Cr 180.86Cr 70Cr 907.87Cr 71Cr 69Cr 2.98TCr
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
4,461
Date Price Change Volume
02/26/02 €3.306 +4.95% 9,06,734
01/26/01 €3.150 -2.96% 8,23,198
31/26/31 €3.246 -3.05% 10,71,165
28/26/28 €3.348 -1.06% 4,21,031
27/26/27 €3.384 +0.89% 3,01,999
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
3.306EUR
Average target price
4.586EUR
Spread / Average Target
+38.71%

Quarterly revenue - Rate of surprise